Catyalyst Pharma (CPRX) Tops Q2 EPS by 1c
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.